The distribution of radioactivity following administration of triethylenephos phoramide-P32 in tumor-bearing and control mice.
D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism*; D051379:Mice; D009369:Neoplasms; D011851:Radioactivity
D000970:Antineoplastic Agents
CYTOTOXIC DRUGS/metabolism